Russia will start giving its first drug approved to treat COVID-19 to patients from June 11, its state financial backer, RDIF sovereign wealth fund head Kirill Dmitriev told Reuters.
The antiviral drug, Avifavir, known generically as Favipiravir, was first developed in the late 1990s by a Japanese company.
https://www.europeanpharmaceuticalreview.com/news/120478/60000-doses-of-avifavir-a-covid-19-treatment-to-be-delivered-in-june/
Cell Therapy News/Articles, page-3130
-
- There are more pages in this discussion • 15,119 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.48 |
Change
0.130(9.63%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.48 | $1.37 | $12.05M | 8.460M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 46673 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.48 | 176784 | 11 |
View Market Depth
| Last trade - 11.45am 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |